Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Announces Quarterly Earnings Results, Misses Estimates By $0.05 EPS

Key Points

• Shionogi reported quarterly EPS of $0.08, missing analysts’ consensus estimate of $0.13 by $0.05. The company posted a 46.67% net margin and 16.13% return on equity.
• Shares fell 0.4% to $9.39, while the stock’s market capitalization stood at approximately $15.98 billion. SGIOY has traded between $7.83 and $12.00 over the past year.
• Despite the earnings miss, analysts remain positive: three research firms rate the stock a Strong Buy, with Zacks Research and Jefferies recently upgrading their ratings.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) released its earnings results on Thursday. The company reported $0.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.13 by ($0.05), Zacks reports. Shionogi & Co., Ltd. Unsponsored ADR had a return on equity of 16.13% and a net margin of 46.67%.

Shionogi & Co., Ltd. Unsponsored ADR Stock Down 0.4%

SGIOY traded down $0.04 on Thursday, reaching $9.39. 29,320 shares of the company traded hands, compared to its average volume of 135,238. The company has a market cap of $15.98 billion, a price-to-earnings ratio of 9.39, a PEG ratio of 3.45 and a beta of 0.08. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.14 and a quick ratio of 1.00. The stock's 50 day moving average price is $9.17 and its 200-day moving average price is $9.64. Shionogi & Co., Ltd. Unsponsored ADR has a 52-week low of $7.83 and a 52-week high of $12.00.

Analyst Ratings Changes

A number of research firms recently commented on SGIOY. Zacks Research upgraded shares of Shionogi & Co., Ltd. Unsponsored ADR from a "hold" rating to a "strong-buy" rating in a report on Thursday, October 15th. Jefferies Financial Group upgraded shares of Shionogi & Co., Ltd. Unsponsored ADR from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, July 14th. Three equities research analysts have rated the stock with a Strong Buy rating. Based on data from MarketBeat, the company presently has an average rating of "Strong Buy".

Shionogi & Co., Ltd. Unsponsored ADR Company Profile

Shionogi & Co, Ltd. is a Japanese pharmaceutical company headquartered in Osaka, Japan. Founded in 1878, the company researches, develops, manufactures and markets prescription medicines, with a longstanding focus on infectious diseases and specialty therapies.

Its products and development programs have included Xofluza (baloxavir marboxil), an oral treatment for influenza; Fetroja (cefiderocol), an antibiotic for certain difficult-to-treat Gram-negative bacterial infections; and medicines for central nervous system disorders, pain and other therapeutic areas.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.